{"ticker": {"uuid": "019ee3ff-0322-4dbf-b92a-a33a1cb24ea9", "symbol": "WUXI13", "name": "WuXi Biologics (Cayman) Inc.", "exchange": "SET", "country": "TH", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "WuXi Biologics Extends Drop to 30% as Weak Outlook Fuels Caution", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPc1JYTk1CYVh2Q2x6VjVLRm5SSUMyOXF5UEhmS1l5UGI3MFAwd29hOUtPOHgwMFNUdXIzVlJHSGRJcjBQODdsVlFaMjZKbXlhNkNIRzVGdF9kc1p1cnd1Q0MtQWFCVmtXQmpuQXNPU3NZYW5DOXBCdy1rRUpMWVhjejQ0aHZnXzM2S1JOR1htV0Y2RnN1UnFkRlRaVVVYLVRvWi04V0lKZnpEMHZUcTVsUEJxX1c?oc=5", "source_name": "Bloomberg.com", "published_at": "2023-12-04T08:00:00+00:00", "published_display": "04 Dec 2023 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "WuXi Biologics Extends Drop to 30% as Weak Outlook Fuels Caution", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPc1JYTk1CYVh2Q2x6VjVLRm5SSUMyOXF5UEhmS1l5UGI3MFAwd29hOUtPOHgwMFNUdXIzVlJHSGRJcjBQODdsVlFaMjZKbXlhNkNIRzVGdF9kc1p1cnd1Q0MtQWFCVmtXQmpuQXNPU3NZYW5DOXBCdy1rRUpMWVhjejQ0aHZnXzM2S1JOR1htV0Y2RnN1UnFkRlRaVVVYLVRvWi04V0lKZnpEMHZUcTVsUEJxX1c?oc=5", "source_name": "Bloomberg.com", "published_at": "2023-12-04T08:00:00+00:00", "published_display": "04 Dec 2023 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 44, "total_relevant": 1, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 0, "score": 34, "total": 1, "label": "Cautious news tone", "tone": "negative"}, "classifier": {"primary_event": "guidance", "primary_label": "Guidance", "confidence": 72, "events": [{"event": "guidance", "label": "Guidance", "weight": 0.9, "count": 1}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 1.92, "latest_week": "2026-06-19", "one_week_move": 0.0, "four_week_move": -4.0, "twelve_week_move": -5.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.874757, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -8.7, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.0, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, -4.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": ["Caution agrees with inactive trend"], "opportunities": [], "risks": ["Negative tone is aligned with an inactive trend backdrop."], "event_label": "Guidance", "sentiment_word": "cautious"}, "charts": {"sources": [{"label": "Bloomberg.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 1}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "34/100", "tone": "negative", "text": "Cautious news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Guidance", "tone": "negative", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "1", "tone": "neutral", "text": "directly relevant article"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, -4.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "WuXi Biologics Extends Drop to 30% as Weak Outlook Fuels Caution"}], "updated_at": "2026-06-22T15:25:13.049228+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}